Cost-effectiveness of tenofovir disoproxil fumarate prophylaxis for perinatal hepatitis B virus prevention in Ethiopia: a decision analytical modeling
Providing TDF prophylaxis for all HBsAg-positive pregnant women starting at 28 weeks of pregnancy has the potential to be a cost-effective strategy in Ethiopia. Introduction of TDF prophylaxis for all HBsAg-positive pregnant women is highly recommended, along with efforts to improve vaccination coverage.
Authors
- Temesgen Kabeta Chala (ORCID: https://orcid.org/0000-0003-4579-6439)
- Firew Tekle Bobo (ORCID: https://orcid.org/0000-0002-0960-1000)
- Negalign Berhanu Bayou (ORCID: https://orcid.org/0000-0002-0975-8358)
- Abdi Gari Negasa
- Desalegn Feleke Falta
Institutions
- The University of Sydney (AU)
- Jimma University (ET)
- Wolaita Sodo University (ET)
- Abt Associates (Nepal) (NP)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1186/s12889-025-22498-6
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00